George A. Eldridge
Chief Financial Officer, Targanta Therapeutics Corporation.
Companies
- Jade Biosciences, Inc.Officer Jun 29, 2021 to Jun 14, 20241
- Targanta Therapeutics CorporationChief financial officer Oct 10, 2007 to Feb 8, 20082
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jade Biosciences, Inc. JBIO5,022 shares3$69.1K at $13.76Jun 14, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 14, 2024Sold 15,000 shares at $25.03 of Jade Biosciences, Inc.3
- Jun 14, 2024Exercised options 15,000 shares at $2.14 of Jade Biosciences, Inc.3
- Apr 10, 2024Sold 771 shares at $27.56 of Jade Biosciences, Inc.4
- Apr 10, 2024Sold 6,729 shares at $26.77 of Jade Biosciences, Inc.4
- Apr 10, 2024Exercised options 7,500 shares at $2.14 of Jade Biosciences, Inc.4
- Apr 1, 2024Sold 12,495 shares at $31.23 of Jade Biosciences, Inc.5
- Apr 1, 2024Exercised options 12,495 shares at $2.14 of Jade Biosciences, Inc.5
- Mar 13, 2024Sold 2,016 shares at $25.02 of Jade Biosciences, Inc.6
- Mar 13, 2024Exercised options 2,016 shares at $2.14 of Jade Biosciences, Inc.6
- Mar 12, 2024Sold 2,051 shares at $25.05 of Jade Biosciences, Inc.6
- Mar 12, 2024Exercised options 2,051 shares at $2.14 of Jade Biosciences, Inc.6
- Mar 11, 2024Sold 10 shares at $26.31 of Jade Biosciences, Inc.7
- Mar 11, 2024Sold 3,423 shares at $25.24 of Jade Biosciences, Inc.7
- Mar 11, 2024Exercised options 3,433 shares at $2.14 of Jade Biosciences, Inc.7
- Mar 8, 2024Sold 114 shares at $25.00 of Jade Biosciences, Inc.7
- Mar 8, 2024Exercised options 114 shares at $2.14 of Jade Biosciences, Inc.7
- Mar 7, 2024Sold 22,386 shares at $25.00 of Jade Biosciences, Inc.7
- Mar 7, 2024Exercised options 22,386 shares at $2.14 of Jade Biosciences, Inc.7
- Dec 12, 2022Sold 10,000 shares at $30.04 of Jade Biosciences, Inc.8
- Dec 12, 2022Exercised options 10,000 shares at $2.14 of Jade Biosciences, Inc.8
- Dec 9, 2022Sold 583 shares at $25.23 of Jade Biosciences, Inc.8
- Dec 9, 2022Sold 3,386 shares at $24.23 of Jade Biosciences, Inc.8
- Dec 9, 2022Exercised options 3,969 shares at $2.14 of Jade Biosciences, Inc.8
- Dec 8, 2022Sold 11,031 shares at $24.20 of Jade Biosciences, Inc.9
- Dec 8, 2022Sold 20 shares at $20.58 of Jade Biosciences, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARJade Biosciences, Inc., Officer
- 2
- 3
- 4SEC EDGARForm 4 filed Apr 12, 2024
- 5SEC EDGARForm 4 filed Apr 3, 2024
- 6SEC EDGARForm 4 filed Mar 14, 2024
- 7SEC EDGARForm 4 filed Mar 11, 2024
- 8SEC EDGARForm 4 filed Dec 13, 2022
- 9SEC EDGARForm 4 filed Dec 9, 2022